CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: selenocysteine derivative
Accession: CHEBI:84208
browse the term
Definition: An amino acid derivative resulting from reaction of selenocysteine at the amino group or the carboxy group, or from the replacement of any hydrogen of selenocysteine by a heteroatom. The definition normally excludes peptides containing selenocysteine residues.
Synonyms: related_synonym: selenocysteine derivatives
G
ABCC1
ATP binding cassette subfamily C member 1 (ABCC1 blood group)
multiple interactions
EXP
[selenomethylselenocysteine co-treated with irinotecan] results in decreased expression of ABCC1
CTD
PMID:15897249
NCBI chr16:15,949,143...16,143,053
Ensembl chr16:15,949,138...16,143,257
G
ABCC4
ATP binding cassette subfamily C member 4 (PEL blood group)
multiple interactions decreases expression
ISO
Isoflavones promotes the reaction [selenomethylselenocysteine results in decreased expression of ABCC4 mRNA]
CTD
PMID:19025659
NCBI chr13:95,019,835...95,301,451
Ensembl chr13:95,019,835...95,301,475
G
APAF1
apoptotic peptidase activating factor 1
increases expression
EXP
selenomethylselenocysteine metabolite results in increased expression of APAF1 mRNA
CTD
PMID:25321483
NCBI chr12:98,645,290...98,735,433
Ensembl chr12:98,645,290...98,735,433
G
AR
androgen receptor
decreases expression
ISO
selenomethylselenocysteine results in decreased expression of AR protein selenomethylselenocysteine results in decreased expression of AR mRNA
CTD
PMID:16637076 PMID:19025659
NCBI chr X:67,544,021...67,730,619
Ensembl chr X:67,544,021...67,730,619
G
BAK1
BCL2 antagonist/killer 1
increases expression
EXP
selenomethylselenocysteine metabolite results in increased expression of BAK1 mRNA
CTD
PMID:25321483
NCBI chr 6:33,572,552...33,580,276
Ensembl chr 6:33,572,547...33,580,293
G
BANP
BTG3 associated nuclear protein
increases expression
EXP
selenomethylselenocysteine results in increased expression of BANP mRNA
CTD
PMID:18514395
NCBI chr16:87,949,238...88,077,318
Ensembl chr16:87,949,244...88,077,318
G
BCL2
BCL2 apoptosis regulator
decreases expression multiple interactions
EXP ISO
selenomethylselenocysteine results in decreased expression of BCL2 mRNA selenomethylselenocysteine results in decreased expression of BCL2 protein [selenomethylselenocysteine results in decreased expression of BCL2 mRNA] which results in increased activity of TNFSF10 protein
CTD
PMID:11396176 PMID:19360359
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
G
BCL2L1
BCL2 like 1
decreases expression
EXP
selenomethylselenocysteine metabolite results in decreased expression of BCL2L1 mRNA
CTD
PMID:25321483
NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
G
BCL2L11
BCL2 like 11
increases expression
EXP
selenomethylselenocysteine metabolite results in increased expression of BCL2L11 mRNA
CTD
PMID:25321483
NCBI chr 2:111,120,914...111,168,445
Ensembl chr 2:111,119,378...111,168,444
G
BMAL1
basic helix-loop-helix ARNT like 1
decreases expression
ISO
selenomethylselenocysteine results in decreased expression of BMAL1 mRNA
CTD
PMID:19122877
NCBI chr11:13,276,652...13,387,266
Ensembl chr11:13,276,652...13,387,266
G
BMF
Bcl2 modifying factor
multiple interactions increases expression
EXP ISO
4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid inhibits the reaction [selenomethylselenocysteine metabolite results in increased expression of BMF mRNA]; BMF protein promotes the reaction [selenomethylselenocysteine metabolite results in increased expression of CASP3 protein modified form]; BMF protein promotes the reaction [selenomethylselenocysteine metabolite results in increased expression of CASP6 protein modified form]; BMF protein promotes the reaction [selenomethylselenocysteine metabolite results in increased expression of CASP9 protein modified form]; BMF protein promotes the reaction [selenomethylselenocysteine metabolite results in increased expression of PARP1 protein modified form]; HDAC8 inhibits the reaction [selenomethylselenocysteine metabolite results in increased expression of BMF mRNA]; selenomethylselenocysteine metabolite inhibits the reaction [HDAC8 protein binds to BMF promoter]; selenomethylselenocysteine metabolite inhibits the reaction [STAT3 protein binds to BMF promoter]; selenomethylselenocysteine metabolite promotes the reaction [EP300 protein binds to BMF promoter]; selenomethylselenocysteine metabolite promotes the reaction [SP3 protein binds to BMF promoter]; STAT3 protein inhibits the reaction [selenomethylselenocysteine metabolite results in increased expression of BMF mRNA] selenomethylselenocysteine metabolite results in increased expression of BMF protein selenomethylselenocysteine metabolite results in increased expression of BMF mRNA; selenomethylselenocysteine metabolite results in increased expression of BMF protein
CTD
PMID:25321483
NCBI chr15:40,087,890...40,108,879
Ensembl chr15:40,087,890...40,108,892
G
CASP3
caspase 3
increases activity increases expression multiple interactions
ISO EXP
selenomethylselenocysteine results in increased activity of CASP3 protein selenomethylselenocysteine metabolite results in increased expression of CASP3 protein modified form BMF protein promotes the reaction [selenomethylselenocysteine metabolite results in increased expression of CASP3 protein modified form]
CTD
PMID:15318939 PMID:25321483
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
CASP6
caspase 6
increases expression multiple interactions
EXP
selenomethylselenocysteine metabolite results in increased expression of CASP6 protein modified form BMF protein promotes the reaction [selenomethylselenocysteine metabolite results in increased expression of CASP6 protein modified form]
CTD
PMID:25321483
NCBI chr 4:109,664,388...109,709,767
Ensembl chr 4:109,688,622...109,703,583
G
CASP8
caspase 8
increases expression
EXP
selenomethylselenocysteine metabolite results in increased expression of CASP8 protein modified form
CTD
PMID:25321483
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
G
CASP9
caspase 9
multiple interactions increases expression
EXP
BMF protein promotes the reaction [selenomethylselenocysteine metabolite results in increased expression of CASP9 protein modified form]
CTD
PMID:25321483
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
G
CCNA2
cyclin A2
decreases expression
ISO
selenomethylselenocysteine results in decreased expression of CCNA2 protein
CTD
PMID:11396176
NCBI chr 4:121,816,444...121,823,883
Ensembl chr 4:121,816,444...121,823,883
G
CCND1
cyclin D1
decreases expression multiple interactions
EXP ISO
selenomethylselenocysteine results in decreased expression of CCND1 protein selenomethylselenocysteine results in decreased expression of CCND1 mRNA; selenomethylselenocysteine results in decreased expression of CCND1 protein [selenomethylselenocysteine co-treated with Tamoxifen] results in decreased expression of CCND1 protein
CTD
PMID:11396176 PMID:18855134 PMID:19276161
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
G
CDK2
cyclin dependent kinase 2
multiple interactions
ISO
selenomethylselenocysteine results in decreased phosphorylation of and results in decreased activity of CDK2 protein
CTD
PMID:10656618
NCBI chr12:55,966,830...55,972,789
Ensembl chr12:55,966,781...55,972,789
G
CDKN1A
cyclin dependent kinase inhibitor 1A
increases expression multiple interactions
EXP
selenomethylselenocysteine metabolite results in increased expression of CDKN1A protein [Aminooxyacetic Acid results in decreased metabolism of selenomethylselenocysteine] which results in decreased expression of CDKN1A protein
CTD
PMID:25321483
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
G
CDKN1B
cyclin dependent kinase inhibitor 1B
increases expression
ISO
selenomethylselenocysteine results in increased expression of CDKN1B protein
CTD
PMID:11396176 PMID:19276161
NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,685,498...12,722,369
G
CES1
carboxylesterase 1
increases expression
EXP
selenomethylselenocysteine results in increased expression of CES1
CTD
PMID:15897249
NCBI chr16:55,802,851...55,833,096
Ensembl chr16:55,802,851...55,833,337
G
CHMP1A
charged multivesicular body protein 1A
increases expression
EXP
selenomethylselenocysteine results in increased expression of CHMP1A mRNA
CTD
PMID:18514395
NCBI chr16:89,644,435...89,657,708
Ensembl chr16:89,640,816...89,657,738
G
COL1A1
collagen type I alpha 1 chain
decreases expression
EXP
selenomethylselenocysteine results in decreased expression of COL1A1 mRNA; selenomethylselenocysteine results in decreased expression of COL1A1 protein
CTD
PMID:18514395
NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632
G
COL1A2
collagen type I alpha 2 chain
decreases expression
EXP
selenomethylselenocysteine results in decreased expression of COL1A2 mRNA; selenomethylselenocysteine results in decreased expression of COL1A2 protein
CTD
PMID:18514395
NCBI chr 7:94,394,895...94,431,227
Ensembl chr 7:94,394,895...94,431,227
G
COL4A5
collagen type IV alpha 5 chain
increases expression
EXP
selenomethylselenocysteine results in increased expression of COL4A5 mRNA
CTD
PMID:18514395
NCBI chr X:108,439,838...108,697,545
Ensembl chr X:108,439,838...108,697,545
G
COL6A1
collagen type VI alpha 1 chain
increases expression
EXP
selenomethylselenocysteine results in increased expression of COL6A1 mRNA
CTD
PMID:18514395
NCBI chr21:45,981,770...46,005,048
Ensembl chr21:45,981,770...46,005,050
G
COL7A1
collagen type VII alpha 1 chain
decreases expression
EXP
selenomethylselenocysteine results in decreased expression of COL7A1 mRNA
CTD
PMID:18514395
NCBI chr 3:48,564,073...48,595,329
Ensembl chr 3:48,564,073...48,595,329
G
CRY2
cryptochrome circadian regulator 2
increases expression
ISO
selenomethylselenocysteine results in increased expression of CRY2 mRNA
CTD
PMID:19122877
NCBI chr11:45,847,118...45,883,244
Ensembl chr11:45,847,118...45,883,248
G
CYP3A5
cytochrome P450 family 3 subfamily A member 5
multiple interactions
EXP
[selenomethylselenocysteine co-treated with irinotecan] results in increased expression of CYP3A5
CTD
PMID:15897249
NCBI chr 7:99,648,194...99,679,996
Ensembl chr 7:99,648,194...99,679,996
G
DBP
D-box binding PAR bZIP transcription factor
increases expression
ISO
selenomethylselenocysteine results in increased expression of DBP mRNA
CTD
PMID:19122877
NCBI chr19:48,630,030...48,637,379
Ensembl chr19:48,630,030...48,637,379
G
DDIT3
DNA damage inducible transcript 3
increases expression
ISO
selenomethylselenocysteine results in increased expression of DDIT3 mRNA
CTD
PMID:10656618
NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
G
DHCR24
24-dehydrocholesterol reductase
decreases expression
ISO
selenomethylselenocysteine results in decreased expression of DHCR24 mRNA
CTD
PMID:19025659
NCBI chr 1:54,849,627...54,887,195
Ensembl chr 1:54,849,627...54,887,195
G
DRG1
developmentally regulated GTP binding protein 1
multiple interactions
EXP
[selenomethylselenocysteine co-treated with irinotecan] results in decreased expression of DRG1
CTD
PMID:15897249
NCBI chr22:31,399,604...31,434,452
Ensembl chr22:31,399,604...31,530,634
G
EP300
E1A binding protein p300
multiple interactions
EXP
selenomethylselenocysteine metabolite promotes the reaction [EP300 protein binds to BMF promoter]
CTD
PMID:25321483
NCBI chr22:41,092,592...41,180,077
Ensembl chr22:41,092,592...41,180,077
G
ESR1
estrogen receptor 1
decreases expression multiple interactions
EXP
selenomethylselenocysteine results in decreased expression of ESR1 protein [selenomethylselenocysteine co-treated with Tamoxifen] results in decreased expression of ESR1 protein
CTD
PMID:18855134
NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
G
FASLG
Fas ligand
multiple interactions
EXP
[selenomethylselenocysteine co-treated with irinotecan] results in increased expression of FASLG
CTD
PMID:15897249
NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
G
GADD45A
growth arrest and DNA damage inducible alpha
increases expression
ISO
selenomethylselenocysteine results in increased expression of GADD45A mRNA
CTD
PMID:10656618
NCBI chr 1:67,685,201...67,688,334
Ensembl chr 1:67,685,201...67,688,334
G
GPX1
glutathione peroxidase 1
increases activity increases expression
EXP
selenomethylselenocysteine results in increased activity of GPX1 protein selenomethylselenocysteine results in increased expression of GPX1 mRNA; selenomethylselenocysteine results in increased expression of GPX1 protein
CTD
PMID:18514395 PMID:19033020
NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605
G
GPX4
glutathione peroxidase 4
increases expression
EXP
selenomethylselenocysteine results in increased expression of GPX4 mRNA
CTD
PMID:18514395
NCBI chr19:1,103,994...1,106,779
Ensembl chr19:1,103,982...1,106,791
G
GRIK1
glutamate ionotropic receptor kainate type subunit 1
increases expression
EXP
selenomethylselenocysteine results in increased expression of GRIK1 mRNA
CTD
PMID:18514395
NCBI chr21:29,536,933...29,939,996
Ensembl chr21:29,536,933...29,940,033
G
GRIK3
glutamate ionotropic receptor kainate type subunit 3
increases expression
EXP
selenomethylselenocysteine results in increased expression of GRIK3 mRNA
CTD
PMID:18514395
NCBI chr 1:36,795,527...37,034,515
Ensembl chr 1:36,795,527...37,034,515
G
HDAC8
histone deacetylase 8
multiple interactions
EXP
HDAC8 inhibits the reaction [selenomethylselenocysteine metabolite results in increased expression of BMF mRNA]; selenomethylselenocysteine metabolite inhibits the reaction [HDAC8 protein binds to BMF promoter]
CTD
PMID:25321483
NCBI chr X:72,329,516...72,572,843
Ensembl chr X:72,329,516...72,573,101
G
IGF1R
insulin like growth factor 1 receptor
increases expression
EXP
selenomethylselenocysteine results in increased expression of IGF1R mRNA
CTD
PMID:18514395
NCBI chr15:98,648,539...98,964,530
Ensembl chr15:98,648,539...98,964,530
G
JUN
Jun proto-oncogene, AP-1 transcription factor subunit
increases phosphorylation
ISO
selenomethylselenocysteine results in increased phosphorylation of JUN protein
CTD
PMID:19276161
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
G
KLK1
kallikrein 1
decreases expression
ISO
selenomethylselenocysteine results in decreased expression of KLK3 protein
CTD
PMID:16637076
NCBI chr19:50,819,146...50,823,787
Ensembl chr19:50,819,146...50,823,787
G
MKI67
marker of proliferation Ki-67
multiple interactions decreases expression
EXP
[selenomethylselenocysteine co-treated with Tamoxifen] results in decreased expression of MKI67 protein selenomethylselenocysteine results in decreased expression of MKI67 protein
CTD
PMID:18855134
NCBI chr10:128,096,659...128,126,423
Ensembl chr10:128,096,659...128,126,423
G
MSRB1
methionine sulfoxide reductase B1
increases expression
EXP
selenomethylselenocysteine results in increased expression of MSRB1 mRNA
CTD
PMID:18514395
NCBI chr16:1,938,229...1,943,199
Ensembl chr16:1,938,229...1,943,199
G
NFKB1
nuclear factor kappa B subunit 1
multiple interactions
ISO
selenomethylselenocysteine inhibits the reaction [Lipopolysaccharides results in increased localization of NFKB1 protein]
CTD
PMID:21213327
NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302
G
NOS2
nitric oxide synthase 2
multiple interactions
ISO
selenomethylselenocysteine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; selenomethylselenocysteine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]
CTD
PMID:21213327
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
P4HA1
prolyl 4-hydroxylase subunit alpha 1
increases expression
EXP
selenomethylselenocysteine results in increased expression of P4HA1 mRNA
CTD
PMID:18514395
NCBI chr10:73,007,217...73,096,866
Ensembl chr10:73,007,217...73,096,974
G
PARP1
poly(ADP-ribose) polymerase 1
multiple interactions increases expression
EXP
[Aminooxyacetic Acid results in decreased metabolism of selenomethylselenocysteine] which results in decreased expression of PARP1 protein modified form; BMF protein promotes the reaction [selenomethylselenocysteine metabolite results in increased expression of PARP1 protein modified form]
CTD
PMID:25321483
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
G
PER2
period circadian regulator 2
increases expression
ISO
selenomethylselenocysteine results in increased expression of PER2 mRNA
CTD
PMID:19122877
NCBI chr 2:238,244,044...238,300,065
Ensembl chr 2:238,244,044...238,290,102
G
PER3
period circadian regulator 3
increases expression
ISO
selenomethylselenocysteine results in increased expression of PER3 mRNA
CTD
PMID:19122877
NCBI chr 1:7,784,291...7,845,177
Ensembl chr 1:7,784,291...7,845,177
G
PGR
progesterone receptor
decreases expression multiple interactions
EXP
selenomethylselenocysteine results in decreased expression of PGR protein [selenomethylselenocysteine co-treated with Tamoxifen] results in decreased expression of PGR protein
CTD
PMID:18855134
NCBI chr11:101,029,624...101,129,813
Ensembl chr11:101,029,624...101,129,813
G
PPP1R15A
protein phosphatase 1 regulatory subunit 15A
increases expression
ISO
selenomethylselenocysteine results in increased expression of PPP1R15A mRNA
CTD
PMID:10656618
NCBI chr19:48,872,421...48,876,058
Ensembl chr19:48,872,212...48,876,059
G
PRKCE
protein kinase C epsilon
decreases expression
ISO
selenomethylselenocysteine results in decreased expression of PRKCE protein
CTD
PMID:10656618
NCBI chr 2:45,651,279...46,187,990
Ensembl chr 2:45,651,345...46,187,990
G
PRKCZ
protein kinase C zeta
decreases expression
ISO
selenomethylselenocysteine results in decreased expression of PRKCZ protein
CTD
PMID:10656618
NCBI chr 1:2,048,504...2,185,395
Ensembl chr 1:2,050,411...2,185,395
G
RAB3B
RAB3B, member RAS oncogene family
increases expression
EXP
selenomethylselenocysteine results in increased expression of RAB3B mRNA
CTD
PMID:18514395
NCBI chr 1:51,907,956...51,990,700
Ensembl chr 1:51,907,956...51,990,700
G
RAB4A
RAB4A, member RAS oncogene family
increases expression
EXP
selenomethylselenocysteine results in increased expression of RAB4A mRNA
CTD
PMID:18514395
NCBI chr 1:229,271,111...229,305,894
Ensembl chr 1:229,271,062...229,305,894
G
RELA
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
selenomethylselenocysteine inhibits the reaction [Lipopolysaccharides results in increased localization of RELA protein]
CTD
PMID:21213327
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
G
SCARB1
scavenger receptor class B member 1
increases expression
EXP
selenomethylselenocysteine results in increased expression of SCARB1 mRNA
CTD
PMID:18514395
NCBI chr12:124,776,856...124,863,864
Ensembl chr12:124,776,856...124,882,668
G
SELENOF
selenoprotein F
increases expression
EXP
selenomethylselenocysteine results in increased expression of SELENOF mRNA
CTD
PMID:18514395
NCBI chr 1:86,862,445...86,914,577
Ensembl chr 1:86,862,445...86,914,424
G
SELENOP
selenoprotein P
increases expression
EXP
selenomethylselenocysteine results in increased expression of SELENOP mRNA
CTD
PMID:18514395
NCBI chr 5:42,799,880...42,811,892
Ensembl chr 5:42,799,880...42,887,392
G
SELENOW
selenoprotein W
increases expression
EXP
selenomethylselenocysteine results in increased expression of SELENOW mRNA
CTD
PMID:18514395
NCBI chr19:47,778,703...47,784,682
Ensembl chr19:47,778,677...47,784,686
G
SLC3A1
solute carrier family 3 member 1
increases uptake
EXP
SLC3A1 protein results in increased uptake of selenomethylselenocysteine
CTD
PMID:18845132
NCBI chr 2:44,275,480...44,322,437
Ensembl chr 2:44,275,458...44,321,494
G
SLC6A19
solute carrier family 6 member 19
increases uptake
ISO
SLC6A19 protein results in increased uptake of selenomethylselenocysteine
CTD
PMID:18845132
NCBI chr 5:1,201,595...1,225,111
Ensembl chr 5:1,201,595...1,225,111
G
SLC6A20
solute carrier family 6 member 20
increases uptake
ISO
SLC6A20B protein results in increased uptake of selenomethylselenocysteine
CTD
PMID:18845132
NCBI chr 3:45,755,449...45,796,536
Ensembl chr 3:45,755,449...45,796,574
G
SNAP23
synaptosome associated protein 23
decreases expression
EXP
selenomethylselenocysteine results in decreased expression of SNAP23 mRNA
CTD
PMID:18514395
NCBI chr15:42,491,129...42,533,058
Ensembl chr15:42,491,233...42,545,356
G
SORT1
sortilin 1
increases expression
EXP
selenomethylselenocysteine results in increased expression of SORT1 mRNA
CTD
PMID:18514395
NCBI chr 1:109,309,575...109,397,918
Ensembl chr 1:109,309,568...109,397,918
G
SP3
Sp3 transcription factor
multiple interactions
EXP
selenomethylselenocysteine metabolite promotes the reaction [SP3 protein binds to BMF promoter]
CTD
PMID:25321483
NCBI chr 2:173,900,775...173,965,702
Ensembl chr 2:173,880,850...173,965,373
G
SPP1
secreted phosphoprotein 1
decreases expression
ISO
selenomethylselenocysteine results in decreased expression of SPP1 protein
CTD
PMID:15318939
NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532
G
SRD5A1
steroid 5 alpha-reductase 1
multiple interactions
ISO
[selenomethylselenocysteine co-treated with Isoflavones] results in decreased activity of SRD5A1 protein
CTD
PMID:19025659
NCBI chr 5:6,633,440...6,674,386
Ensembl chr 5:6,633,290...6,676,539
G
STAT3
signal transducer and activator of transcription 3
multiple interactions
EXP
selenomethylselenocysteine metabolite inhibits the reaction [STAT3 protein binds to BMF promoter]; STAT3 protein inhibits the reaction [selenomethylselenocysteine metabolite results in increased expression of BMF mRNA]
CTD
PMID:25321483
NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,568
G
STX3
syntaxin 3
increases expression
EXP
selenomethylselenocysteine results in increased expression of STX3 mRNA
CTD
PMID:18514395
NCBI chr11:59,754,188...59,805,878
Ensembl chr11:59,713,456...59,805,882
G
TNFSF10
TNF superfamily member 10
multiple interactions
EXP
[selenomethylselenocysteine results in decreased expression of BCL2 mRNA] which results in increased activity of TNFSF10 protein
CTD
PMID:19360359
NCBI chr 3:172,505,508...172,523,430
Ensembl chr 3:172,505,508...172,523,475
G
TRNAU1AP
tRNA selenocysteine 1 associated protein 1
increases expression
EXP
selenomethylselenocysteine results in increased expression of TRNAU1AP mRNA
CTD
PMID:18514395
NCBI chr 1:28,553,085...28,578,545
Ensembl chr 1:28,553,085...28,578,545
G
XPA
XPA, DNA damage recognition and repair factor
multiple interactions
EXP
selenomethylselenocysteine inhibits the reaction [Zinc binds to XPA protein]
CTD
PMID:15265038
NCBI chr 9:97,654,398...97,697,340
Ensembl chr 9:97,674,909...97,697,340
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all